| 0 |
APPLICATION SITE MOVEMENT IMPAIRMENT |
1 |
0.1667 |
| 1 |
VIITH NERVE INJURY |
10 |
0.1235 |
| 2 |
ADMINISTRATION SITE SCAB |
3 |
0.1154 |
| 3 |
APPLICATION SITE ALOPECIA |
6 |
0.1091 |
| 4 |
INJECTION SITE ALOPECIA |
4 |
0.0909 |
| 5 |
ADMINISTRATION SITE INDURATION |
8 |
0.0889 |
| 6 |
INJECTION SITE DEFORMATION |
6 |
0.0674 |
| 7 |
VTH NERVE INJURY |
3 |
0.0612 |
| 8 |
SKIN PROCEDURAL COMPLICATION |
1 |
0.0588 |
| 9 |
FACIAL ASYMMETRY |
54 |
0.0566 |
| 10 |
CUTANEOUS CONTOUR DEFORMITY |
1 |
0.0526 |
| 11 |
TRIGEMINAL NERVE PARESIS |
1 |
0.0526 |
| 12 |
SKIN LAXITY |
23 |
0.0525 |
| 13 |
APPLICATION SITE PLAQUE |
1 |
0.0435 |
| 14 |
FACIAL PARESIS |
130 |
0.0367 |
| 15 |
INJECTION SITE HYPOAESTHESIA |
52 |
0.0363 |
| 16 |
ADMINISTRATION SITE ABSCESS |
1 |
0.0294 |
| 17 |
FAT TISSUE INCREASED |
41 |
0.0283 |
| 18 |
GASTRIC HYPERTONIA |
1 |
0.0270 |
| 19 |
INJECTION SITE PALLOR |
8 |
0.0253 |
| 20 |
ADMINISTRATION SITE NECROSIS |
1 |
0.0250 |
| 21 |
EXCESSIVE SKIN |
7 |
0.0248 |
| 22 |
INJECTION SITE ULCER |
22 |
0.0233 |
| 23 |
SKIN INDENTATION |
11 |
0.0233 |
| 24 |
PERIORBITAL FAT ATROPHY |
1 |
0.0233 |
| 25 |
NECROSIS OF ARTERY |
1 |
0.0222 |
| 26 |
TRIGEMINAL PALSY |
1 |
0.0217 |
| 27 |
CRANIAL NERVE INJURY |
2 |
0.0206 |
| 28 |
PELVIC MISALIGNMENT |
1 |
0.0196 |
| 29 |
INDURATION |
34 |
0.0191 |
| 30 |
INJECTION SITE JOINT SWELLING |
1 |
0.0179 |
| 31 |
INJECTION SITE NERVE DAMAGE |
4 |
0.0167 |
| 32 |
ADMINISTRATION SITE DISCOLOURATION |
2 |
0.0160 |
| 33 |
INJECTION SITE HYPERAESTHESIA |
3 |
0.0155 |
| 34 |
SOFT TISSUE ATROPHY |
1 |
0.0141 |
| 35 |
INJECTION SITE ISCHAEMIA |
1 |
0.0139 |
| 36 |
INJECTION SITE NECROSIS |
28 |
0.0137 |
| 37 |
ORAL MUCOSA HAEMATOMA |
1 |
0.0137 |
| 38 |
INJECTION SITE HYPERTROPHY |
4 |
0.0123 |
| 39 |
ADMINISTRATION SITE WARMTH |
1 |
0.0122 |
| 40 |
INJECTION SITE SCAB |
11 |
0.0114 |
| 41 |
MANDIBULAR MASS |
1 |
0.0114 |
| 42 |
NECK DEFORMITY |
5 |
0.0113 |
| 43 |
INJECTION SITE NODULE |
123 |
0.0112 |
| 44 |
TONGUE THRUST |
1 |
0.0111 |
| 45 |
PROGNATHISM |
1 |
0.0106 |
| 46 |
NIPPLE EXUDATE BLOODY |
2 |
0.0106 |
| 47 |
KOEBNER PHENOMENON |
1 |
0.0104 |
| 48 |
NERVE INJURY |
115 |
0.0103 |
| 49 |
PROPIONIBACTERIUM INFECTION |
1 |
0.0094 |
| 50 |
JAW CLICKING |
2 |
0.0094 |
| 51 |
RENAL PAPILLARY NECROSIS |
2 |
0.0093 |
| 52 |
TISSUE INJURY |
4 |
0.0092 |
| 53 |
FACIAL NERVE DISORDER |
4 |
0.0090 |
| 54 |
VASCULAR OCCLUSION |
19 |
0.0090 |
| 55 |
POST INFLAMMATORY PIGMENTATION CHANGE |
4 |
0.0088 |
| 56 |
MALPOSITIONED TEETH |
1 |
0.0087 |
| 57 |
INJECTION SITE FIBROSIS |
1 |
0.0085 |
| 58 |
INJECTION SITE GRANULOMA |
2 |
0.0084 |
| 59 |
VASCULAR INJURY |
12 |
0.0083 |
| 60 |
CORONARY ARTERY PERFORATION |
1 |
0.0081 |
| 61 |
COUGH DECREASED |
1 |
0.0075 |
| 62 |
INJECTION SITE EXFOLIATION |
5 |
0.0075 |
| 63 |
FACIAL WASTING |
2 |
0.0074 |
| 64 |
CUTIS LAXA |
2 |
0.0074 |
| 65 |
APPLICATION SITE NODULE |
1 |
0.0073 |
| 66 |
ERYTHEMA INDURATUM |
1 |
0.0070 |
| 67 |
INJECTION SITE DERMATITIS |
1 |
0.0069 |
| 68 |
INJECTION SITE CYST |
2 |
0.0068 |
| 69 |
PARAESTHESIA EAR |
1 |
0.0068 |
| 70 |
DERMATOCHALASIS |
1 |
0.0068 |
| 71 |
PATIENT DISSATISFACTION WITH TREATMENT |
13 |
0.0067 |
| 72 |
ARTERIAL INJURY |
5 |
0.0067 |
| 73 |
INJECTION SITE SCAR |
19 |
0.0067 |
| 74 |
INJECTION SITE INDURATION |
86 |
0.0066 |
| 75 |
FACIAL OPERATION |
1 |
0.0062 |
| 76 |
ADMINISTRATION SITE SWELLING |
2 |
0.0062 |
| 77 |
APPLICATION SITE INDURATION |
1 |
0.0059 |
| 78 |
INJECTION SITE PARAESTHESIA |
9 |
0.0059 |
| 79 |
SPEECH SOUND DISORDER |
1 |
0.0058 |
| 80 |
INJECTION SITE EROSION |
2 |
0.0057 |
| 81 |
MULTIFOCAL MOTOR NEUROPATHY |
1 |
0.0057 |
| 82 |
THYROID PAIN |
1 |
0.0056 |
| 83 |
SKIN WRINKLING |
15 |
0.0055 |
| 84 |
ADMINISTRATION SITE DISCOMFORT |
1 |
0.0053 |
| 85 |
APPLICATION SITE INJURY |
1 |
0.0053 |
| 86 |
INJECTION SITE PUSTULE |
2 |
0.0052 |
| 87 |
INJECTION SITE OEDEMA |
9 |
0.0052 |
| 88 |
FAT TISSUE DECREASED |
2 |
0.0051 |
| 89 |
ADMINISTRATION RELATED REACTION |
1 |
0.0051 |
| 90 |
LEUKODERMA |
1 |
0.0050 |
| 91 |
LIPOHYPERTROPHY |
3 |
0.0048 |
| 92 |
PELVIC FLOOR DYSFUNCTION |
1 |
0.0047 |
| 93 |
PRODUCT ADVERTISING ISSUE |
1 |
0.0047 |
| 94 |
HYPERPLASIA |
4 |
0.0044 |
| 95 |
NEURALGIC AMYOTROPHY |
1 |
0.0044 |
| 96 |
SOFT TISSUE MASS |
2 |
0.0043 |
| 97 |
ORAL CONTUSION |
1 |
0.0043 |
| 98 |
FAT REDISTRIBUTION |
1 |
0.0043 |
| 99 |
ORAL PUSTULE |
1 |
0.0043 |
| 100 |
APPLICATION SITE HYPOAESTHESIA |
1 |
0.0043 |
| 101 |
LIPOATROPHY |
4 |
0.0042 |
| 102 |
SKIN TEXTURE ABNORMAL |
4 |
0.0042 |
| 103 |
INJECTION SITE SWELLING |
305 |
0.0040 |
| 104 |
SKIN INDURATION |
8 |
0.0039 |
| 105 |
BODY FAT DISORDER |
2 |
0.0037 |
| 106 |
LIP DISORDER |
7 |
0.0037 |
| 107 |
SOFT TISSUE DISORDER |
4 |
0.0036 |
| 108 |
NODULE |
46 |
0.0035 |
| 109 |
FACIAL PARALYSIS |
30 |
0.0035 |
| 110 |
ADMINISTRATION SITE ERYTHEMA |
1 |
0.0035 |
| 111 |
INJECTION SITE INFLAMMATION |
17 |
0.0034 |
| 112 |
PREMATURE AGEING |
1 |
0.0034 |
| 113 |
FROSTBITE |
1 |
0.0033 |
| 114 |
HEAD DEFORMITY |
1 |
0.0033 |
| 115 |
MALABSORPTION FROM INJECTION SITE |
1 |
0.0032 |
| 116 |
TENDERNESS |
33 |
0.0032 |
| 117 |
SOFT TISSUE INFLAMMATION |
1 |
0.0030 |
| 118 |
CYST RUPTURE |
2 |
0.0029 |
| 119 |
MUSCLE HYPERTROPHY |
1 |
0.0028 |
| 120 |
INJECTION SITE MASS |
104 |
0.0028 |
| 121 |
SWELLING |
262 |
0.0028 |
| 122 |
SKIN TIGHTNESS |
13 |
0.0028 |
| 123 |
SHOCK SYMPTOM |
1 |
0.0027 |
| 124 |
SKIN NECROSIS |
14 |
0.0027 |
| 125 |
INJECTION SITE CELLULITIS |
5 |
0.0027 |
| 126 |
LID SULCUS DEEPENED |
1 |
0.0027 |
| 127 |
POLYCYSTIC OVARIAN SYNDROME |
1 |
0.0026 |
| 128 |
CAPILLARY DISORDER |
1 |
0.0026 |
| 129 |
NEUTROPHILIC DERMATOSIS |
1 |
0.0025 |
| 130 |
INJECTION SITE DISCOLOURATION |
31 |
0.0025 |
| 131 |
GRANULOMA SKIN |
2 |
0.0024 |
| 132 |
INJECTION SITE ATROPHY |
4 |
0.0024 |
| 133 |
SKIN WOUND |
4 |
0.0024 |
| 134 |
TONGUE MOVEMENT DISTURBANCE |
2 |
0.0023 |
| 135 |
LIP PRURITUS |
2 |
0.0023 |
| 136 |
INJECTION SITE INDENTATION |
5 |
0.0023 |
| 137 |
REFLUX LARYNGITIS |
1 |
0.0023 |
| 138 |
HYPOAESTHESIA ORAL |
34 |
0.0023 |
| 139 |
NUCHAL RIGIDITY |
2 |
0.0022 |
| 140 |
CHLOASMA |
1 |
0.0022 |
| 141 |
INJECTION SITE INFECTION |
7 |
0.0021 |
| 142 |
CRANIAL NERVE PARALYSIS |
1 |
0.0021 |
| 143 |
OPEN FRACTURE |
1 |
0.0021 |
| 144 |
APPLICATION SITE BRUISE |
2 |
0.0021 |
| 145 |
INJECTION SITE ABSCESS |
5 |
0.0020 |
| 146 |
INJECTION SITE DISCOMFORT |
21 |
0.0020 |
| 147 |
ADHESION |
3 |
0.0020 |
| 148 |
ACCIDENT AT HOME |
1 |
0.0019 |
| 149 |
KELOID SCAR |
1 |
0.0019 |
| 150 |
TRI-IODOTHYRONINE DECREASED |
1 |
0.0019 |
| 151 |
DEVICE USE CONFUSION |
1 |
0.0019 |
| 152 |
FACIAL PAIN |
17 |
0.0019 |
| 153 |
TEMPOROMANDIBULAR JOINT SYNDROME |
5 |
0.0019 |
| 154 |
HYPERTROPHY |
1 |
0.0018 |
| 155 |
POST PROCEDURAL SWELLING |
2 |
0.0018 |
| 156 |
INJECTION SITE VESICLES |
11 |
0.0018 |
| 157 |
LIFE SUPPORT |
1 |
0.0018 |
| 158 |
COLLAGEN DISORDER |
1 |
0.0017 |
| 159 |
CHEMICAL BURN |
2 |
0.0017 |
| 160 |
ALOPECIA AREATA |
3 |
0.0017 |
| 161 |
HYPOAESTHESIA EYE |
1 |
0.0017 |
| 162 |
PUSTULE |
4 |
0.0017 |
| 163 |
LYMPHATIC DISORDER |
1 |
0.0017 |
| 164 |
FAT NECROSIS |
1 |
0.0016 |
| 165 |
ALLERGY TO METALS |
1 |
0.0016 |
| 166 |
SEROMA |
2 |
0.0016 |
| 167 |
SPIDER VEIN |
1 |
0.0016 |
| 168 |
HYPOTRICHOSIS |
1 |
0.0016 |
| 169 |
IATROGENIC INJURY |
2 |
0.0016 |
| 170 |
NASAL SEPTUM PERFORATION |
1 |
0.0015 |
| 171 |
PAROTID GLAND ENLARGEMENT |
1 |
0.0015 |
| 172 |
COUNTERFEIT PRODUCT ADMINISTERED |
2 |
0.0015 |
| 173 |
GINGIVAL DISCOMFORT |
1 |
0.0015 |
| 174 |
ABSCESS NECK |
1 |
0.0015 |
| 175 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
27 |
0.0015 |
| 176 |
CLUSTER HEADACHE |
2 |
0.0015 |
| 177 |
INJECTION SITE MACULE |
1 |
0.0015 |
| 178 |
SOFT TISSUE NECROSIS |
1 |
0.0015 |
| 179 |
RADIOISOTOPE SCAN ABNORMAL |
1 |
0.0014 |
| 180 |
FACIAL DISCOMFORT |
1 |
0.0014 |
| 181 |
APPLICATION SITE SWELLING |
7 |
0.0014 |
| 182 |
MYCOBACTERIUM ABSCESSUS INFECTION |
1 |
0.0014 |
| 183 |
CALCINOSIS |
3 |
0.0013 |
| 184 |
IMPETIGO |
2 |
0.0013 |
| 185 |
CREATININE RENAL CLEARANCE INCREASED |
1 |
0.0013 |
| 186 |
TENDON DISCOMFORT |
1 |
0.0013 |
| 187 |
BLOOD KETONE BODY INCREASED |
1 |
0.0013 |
| 188 |
SKIN HYPERPIGMENTATION |
11 |
0.0013 |
| 189 |
INJECTION SITE HYPERSENSITIVITY |
4 |
0.0013 |
| 190 |
MAMMOPLASTY |
1 |
0.0013 |
| 191 |
OCCUPATIONAL EXPOSURE TO PRODUCT |
8 |
0.0012 |
| 192 |
EXCESSIVE GRANULATION TISSUE |
1 |
0.0012 |
| 193 |
PAIN IN JAW |
35 |
0.0012 |
| 194 |
CHEMICAL INJURY |
1 |
0.0012 |
| 195 |
DENTAL DISCOMFORT |
1 |
0.0012 |
| 196 |
LIPOMA |
3 |
0.0012 |
| 197 |
SPINAL CORD INJURY |
2 |
0.0011 |
| 198 |
MASS |
16 |
0.0011 |
| 199 |
SKIN HYPOPIGMENTATION |
2 |
0.0011 |
| 200 |
PARAESTHESIA ORAL |
16 |
0.0011 |
| 201 |
INJECTION SITE DRYNESS |
1 |
0.0011 |
| 202 |
VASOSPASM |
1 |
0.0011 |
| 203 |
PHARYNGEAL HYPOAESTHESIA |
1 |
0.0011 |
| 204 |
VENOUS INJURY |
1 |
0.0011 |
| 205 |
DEFORMITY |
10 |
0.0011 |
| 206 |
SKIN HYPERTROPHY |
3 |
0.0011 |
| 207 |
THERAPEUTIC RESPONSE INCREASED |
1 |
0.0011 |
| 208 |
NECK MASS |
3 |
0.0011 |
| 209 |
FACE INJURY |
4 |
0.0011 |
| 210 |
SCAB |
12 |
0.0011 |
| 211 |
PARALYSIS |
15 |
0.0010 |
| 212 |
LIP PAIN |
3 |
0.0010 |
| 213 |
ACTINOMYCOSIS |
1 |
0.0010 |
| 214 |
NECK INJURY |
3 |
0.0010 |
| 215 |
WRONG DRUG ADMINISTERED |
9 |
0.0010 |
| 216 |
ADMINISTRATION SITE EXTRAVASATION |
1 |
0.0010 |
| 217 |
REDUCED FACIAL EXPRESSION |
1 |
0.0010 |
| 218 |
BENIGN BREAST NEOPLASM |
1 |
0.0010 |
| 219 |
MASTICATION DISORDER |
3 |
0.0010 |
| 220 |
LIVEDO RETICULARIS |
2 |
0.0010 |
| 221 |
INJECTION SITE BRUISING |
76 |
0.0010 |
| 222 |
PHARYNGEAL ERYTHEMA |
2 |
0.0009 |
| 223 |
SKIN SWELLING |
8 |
0.0009 |
| 224 |
PALLOR |
25 |
0.0009 |
| 225 |
FEAR OF DEATH |
2 |
0.0009 |
| 226 |
CONTUSION |
85 |
0.0009 |
| 227 |
INJECTION SITE PAPULE |
4 |
0.0009 |
| 228 |
SKIN ATROPHY |
5 |
0.0009 |
| 229 |
MUCOSAL HAEMORRHAGE |
1 |
0.0009 |
| 230 |
THERAPEUTIC PRODUCT EFFECT INCREASED |
1 |
0.0009 |
| 231 |
LIP ULCERATION |
1 |
0.0009 |
| 232 |
THERMAL BURN |
6 |
0.0008 |
| 233 |
ODYNOPHAGIA |
5 |
0.0008 |
| 234 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
1 |
0.0008 |
| 235 |
ORAL MUCOSA EROSION |
1 |
0.0008 |
| 236 |
VICTIM OF CRIME |
1 |
0.0008 |
| 237 |
ALLERGY TO CHEMICALS |
1 |
0.0008 |
| 238 |
SUBCUTANEOUS HAEMATOMA |
1 |
0.0008 |
| 239 |
SWELLING FACE |
51 |
0.0008 |
| 240 |
INJECTION SITE WARMTH |
16 |
0.0008 |
| 241 |
TRISMUS |
4 |
0.0008 |
| 242 |
WOUND SECRETION |
3 |
0.0008 |
| 243 |
LIP INJURY |
1 |
0.0008 |
| 244 |
LIP EXFOLIATION |
1 |
0.0008 |
| 245 |
SKIN MASS |
5 |
0.0007 |
| 246 |
WRONG PRODUCT ADMINISTERED |
5 |
0.0007 |
| 247 |
OFF LABEL USE OF DEVICE |
1 |
0.0007 |
| 248 |
TONGUE DRY |
1 |
0.0007 |
| 249 |
SKIN ULCER |
19 |
0.0007 |
| 250 |
HYPOAESTHESIA |
110 |
0.0007 |
| 251 |
SKIN DEPIGMENTATION |
1 |
0.0007 |
| 252 |
EFFUSION |
1 |
0.0007 |
| 253 |
ABSCESS ORAL |
1 |
0.0007 |
| 254 |
CORNEAL ABRASION |
1 |
0.0007 |
| 255 |
NASAL DISCHARGE DISCOLOURATION |
1 |
0.0007 |
| 256 |
THYROID NEOPLASM |
2 |
0.0007 |
| 257 |
INCISIONAL HERNIA |
1 |
0.0007 |
| 258 |
THERAPEUTIC PROCEDURE |
1 |
0.0007 |
| 259 |
SCAR |
12 |
0.0007 |
| 260 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
12 |
0.0007 |
| 261 |
TENSION HEADACHE |
3 |
0.0007 |
| 262 |
DARK CIRCLES UNDER EYES |
1 |
0.0007 |
| 263 |
LYMPHADENOPATHY |
24 |
0.0007 |
| 264 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
7 |
0.0007 |
| 265 |
IMMUNE-MEDIATED ADVERSE REACTION |
1 |
0.0007 |
| 266 |
SKIN DISCOLOURATION |
29 |
0.0006 |
| 267 |
PHARYNGEAL PARAESTHESIA |
1 |
0.0006 |
| 268 |
INJECTION SITE PAIN |
191 |
0.0006 |
| 269 |
SENSORY LOSS |
5 |
0.0006 |
| 270 |
INJECTION SITE RASH |
19 |
0.0006 |
| 271 |
MUSCLE TIGHTNESS |
10 |
0.0006 |
| 272 |
MUSCLE DISORDER |
5 |
0.0006 |
| 273 |
OROPHARYNGEAL BLISTERING |
1 |
0.0006 |
| 274 |
SPLENIC RUPTURE |
1 |
0.0006 |
| 275 |
TOOTHACHE |
11 |
0.0006 |
| 276 |
SKIN INJURY |
2 |
0.0006 |
| 277 |
GASTRIC DILATATION |
1 |
0.0006 |
| 278 |
VEIN RUPTURE |
1 |
0.0006 |
| 279 |
TONSILLAR HYPERTROPHY |
1 |
0.0006 |
| 280 |
GENERAL PHYSICAL CONDITION ABNORMAL |
4 |
0.0006 |
| 281 |
EAR DISCOMFORT |
6 |
0.0006 |
| 282 |
CERVICAL SPINAL STENOSIS |
1 |
0.0006 |
| 283 |
PRODUCT COUNTERFEIT |
1 |
0.0006 |
| 284 |
SENSITIVITY OF TEETH |
1 |
0.0006 |
| 285 |
GRANULOMA |
2 |
0.0006 |
| 286 |
NECK PAIN |
32 |
0.0006 |
| 287 |
BURNS SECOND DEGREE |
1 |
0.0006 |
| 288 |
PAPULE |
4 |
0.0006 |
| 289 |
BREAST CYST |
1 |
0.0006 |
| 290 |
PYODERMA GANGRENOSUM |
2 |
0.0006 |
| 291 |
ABORTION INCOMPLETE |
1 |
0.0005 |
| 292 |
ANGIOPATHY |
3 |
0.0005 |
| 293 |
TUNNEL VISION |
1 |
0.0005 |
| 294 |
PERIORBITAL SWELLING |
3 |
0.0005 |
| 295 |
MYELOPATHY |
1 |
0.0005 |
| 296 |
GINGIVAL RECESSION |
1 |
0.0005 |
| 297 |
MOUTH SWELLING |
3 |
0.0005 |
| 298 |
INJECTION SITE ERYTHEMA |
64 |
0.0005 |
| 299 |
SKIN WARM |
3 |
0.0005 |
| 300 |
ARTERIAL OCCLUSIVE DISEASE |
4 |
0.0005 |
| 301 |
HYPERAEMIA |
1 |
0.0005 |
| 302 |
ANORECTAL DISORDER |
1 |
0.0005 |
| 303 |
LIBIDO INCREASED |
1 |
0.0005 |
| 304 |
EYELID PAIN |
1 |
0.0005 |
| 305 |
LIP SWELLING |
16 |
0.0005 |
| 306 |
SENSATION OF FOREIGN BODY |
4 |
0.0005 |
| 307 |
OPTIC NEUROPATHY |
1 |
0.0005 |
| 308 |
EXPOSED BONE IN JAW |
1 |
0.0005 |
| 309 |
CHAPPED LIPS |
2 |
0.0005 |
| 310 |
LOCAL SWELLING |
8 |
0.0005 |
| 311 |
SKIN DISORDER |
15 |
0.0004 |
| 312 |
SENSORY DISTURBANCE |
7 |
0.0004 |
| 313 |
ORAL PRURITUS |
1 |
0.0004 |
| 314 |
EYELID DISORDER |
1 |
0.0004 |
| 315 |
LOCALISED OEDEMA |
2 |
0.0004 |
| 316 |
LICHEN PLANUS |
1 |
0.0004 |
| 317 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
23 |
0.0004 |
| 318 |
PANIC REACTION |
3 |
0.0004 |
| 319 |
PULSE ABNORMAL |
1 |
0.0004 |
| 320 |
SELF ESTEEM DECREASED |
1 |
0.0004 |
| 321 |
EAR PAIN |
8 |
0.0004 |
| 322 |
DYSPHAGIA |
39 |
0.0004 |
| 323 |
ORAL DISORDER |
3 |
0.0004 |
| 324 |
INFLAMMATION |
21 |
0.0004 |
| 325 |
SUFFOCATION FEELING |
1 |
0.0004 |
| 326 |
VASODILATATION |
1 |
0.0004 |
| 327 |
VULVOVAGINAL PRURITUS |
2 |
0.0004 |
| 328 |
CHEMICAL BURN OF SKIN |
1 |
0.0004 |
| 329 |
INJECTION SITE IRRITATION |
5 |
0.0004 |
| 330 |
EXPIRED PRODUCT ADMINISTERED |
13 |
0.0004 |
| 331 |
MUSCLE TWITCHING |
9 |
0.0004 |
| 332 |
PRODUCT COLOUR ISSUE |
2 |
0.0004 |
| 333 |
ANAESTHETIC COMPLICATION |
1 |
0.0004 |
| 334 |
INJECTION SITE DISCHARGE |
2 |
0.0004 |
| 335 |
MIGRAINE WITH AURA |
1 |
0.0004 |
| 336 |
LIP BLISTER |
1 |
0.0004 |
| 337 |
HYPERAESTHESIA |
3 |
0.0004 |
| 338 |
TYPE IV HYPERSENSITIVITY REACTION |
1 |
0.0004 |
| 339 |
CHOKING SENSATION |
2 |
0.0004 |
| 340 |
INJECTION SITE INJURY |
2 |
0.0004 |
| 341 |
NECROSIS |
2 |
0.0004 |
| 342 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
2 |
0.0004 |
| 343 |
OESOPHAGEAL STENOSIS |
1 |
0.0004 |
| 344 |
VOMITING PROJECTILE |
1 |
0.0003 |
| 345 |
TOOTH DISCOLOURATION |
1 |
0.0003 |
| 346 |
ACNE CYSTIC |
1 |
0.0003 |
| 347 |
OFF LABEL USE |
287 |
0.0003 |
| 348 |
FIBROSIS |
1 |
0.0003 |
| 349 |
CHOLANGITIS |
2 |
0.0003 |
| 350 |
SWOLLEN TONGUE |
10 |
0.0003 |
| 351 |
BLOOD BLISTER |
1 |
0.0003 |
| 352 |
CUSHINGOID |
1 |
0.0003 |
| 353 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
63 |
0.0003 |
| 354 |
SKIN EROSION |
1 |
0.0003 |
| 355 |
SPEECH DISORDER |
16 |
0.0003 |
| 356 |
PRODUCT PREPARATION ISSUE |
2 |
0.0003 |
| 357 |
ASPERGILLUS INFECTION |
2 |
0.0003 |
| 358 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
1 |
0.0003 |
| 359 |
HYPOTONIA |
3 |
0.0003 |
| 360 |
BK VIRUS INFECTION |
1 |
0.0003 |
| 361 |
B-CELL LYMPHOMA |
1 |
0.0003 |
| 362 |
ECCHYMOSIS |
2 |
0.0003 |
| 363 |
WOUND COMPLICATION |
1 |
0.0003 |
| 364 |
DROOLING |
2 |
0.0003 |
| 365 |
ENCEPHALITIS |
2 |
0.0003 |
| 366 |
HAIR GROWTH ABNORMAL |
2 |
0.0003 |
| 367 |
HYPOPNOEA |
1 |
0.0003 |
| 368 |
PRESYNCOPE |
7 |
0.0003 |
| 369 |
ORAL DISCOMFORT |
4 |
0.0003 |
| 370 |
APHONIA |
4 |
0.0003 |
| 371 |
EAR PRURITUS |
1 |
0.0003 |
| 372 |
DEVICE PLACEMENT ISSUE |
1 |
0.0003 |
| 373 |
OEDEMA |
15 |
0.0003 |
| 374 |
TONGUE DISORDER |
2 |
0.0003 |
| 375 |
BIPOLAR DISORDER |
3 |
0.0003 |
| 376 |
INJECTION SITE HAEMATOMA |
4 |
0.0003 |
| 377 |
PARADOXICAL DRUG REACTION |
1 |
0.0003 |
| 378 |
HYPERACUSIS |
1 |
0.0003 |
| 379 |
DISCOMFORT |
16 |
0.0003 |
| 380 |
PROCEDURAL COMPLICATION |
2 |
0.0003 |
| 381 |
OESOPHAGEAL DISORDER |
1 |
0.0003 |
| 382 |
VIRAL LOAD INCREASED |
1 |
0.0003 |
| 383 |
PULMONARY HAEMORRHAGE |
2 |
0.0003 |
| 384 |
ABSCESS |
4 |
0.0003 |
| 385 |
OBSTRUCTION |
1 |
0.0003 |
| 386 |
FOREIGN BODY |
1 |
0.0002 |
| 387 |
BLISTER |
14 |
0.0002 |
| 388 |
ORGAN FAILURE |
1 |
0.0002 |
| 389 |
DRUG INEFFECTIVE |
327 |
0.0002 |
| 390 |
PRODUCT ADMINISTRATION ERROR |
5 |
0.0002 |
| 391 |
GOITRE |
1 |
0.0002 |
| 392 |
CONDITION AGGRAVATED |
74 |
0.0002 |
| 393 |
PRODUCT PREPARATION ERROR |
5 |
0.0002 |
| 394 |
SOCIAL PROBLEM |
1 |
0.0002 |
| 395 |
MUSCLE INJURY |
2 |
0.0002 |
| 396 |
DERMATITIS |
5 |
0.0002 |
| 397 |
MUSCLE ATROPHY |
3 |
0.0002 |
| 398 |
TONGUE DISCOMFORT |
1 |
0.0002 |
| 399 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 400 |
PSEUDOMONAS INFECTION |
2 |
0.0002 |
| 401 |
HAEMATOMA |
6 |
0.0002 |
| 402 |
HORDEOLUM |
1 |
0.0002 |
| 403 |
TONGUE DISCOLOURATION |
1 |
0.0002 |
| 404 |
DYSPHEMIA |
1 |
0.0002 |
| 405 |
LIGAMENT RUPTURE |
1 |
0.0002 |
| 406 |
CYTOMEGALOVIRUS VIRAEMIA |
1 |
0.0002 |
| 407 |
INJECTION SITE PRURITUS |
15 |
0.0002 |
| 408 |
LIP DRY |
2 |
0.0002 |
| 409 |
ALOPECIA |
43 |
0.0002 |
| 410 |
ISCHAEMIA |
1 |
0.0002 |
| 411 |
INTERCEPTED MEDICATION ERROR |
1 |
0.0002 |
| 412 |
EYE SWELLING |
8 |
0.0002 |
| 413 |
THERAPEUTIC RESPONSE DECREASED |
13 |
0.0002 |
| 414 |
ERYTHEMA |
44 |
0.0002 |
| 415 |
MUSCULOSKELETAL DISORDER |
4 |
0.0002 |
| 416 |
RASH ERYTHEMATOUS |
10 |
0.0002 |
| 417 |
LIMB OPERATION |
1 |
0.0002 |
| 418 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 419 |
AUTOIMMUNE DISORDER |
2 |
0.0002 |
| 420 |
PHARYNGEAL SWELLING |
2 |
0.0002 |
| 421 |
INJECTION SITE URTICARIA |
5 |
0.0002 |
| 422 |
APPLICATION SITE BURN |
1 |
0.0002 |
| 423 |
DYSKINESIA |
8 |
0.0002 |
| 424 |
PERIPHERAL VASCULAR DISORDER |
1 |
0.0002 |
| 425 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 426 |
TONSILLITIS |
1 |
0.0002 |
| 427 |
WEIGHT FLUCTUATION |
2 |
0.0002 |
| 428 |
ULCER |
3 |
0.0002 |
| 429 |
DYSARTHRIA |
7 |
0.0002 |
| 430 |
PAIN OF SKIN |
5 |
0.0002 |
| 431 |
BURNING SENSATION |
13 |
0.0002 |
| 432 |
CHEILITIS |
1 |
0.0002 |
| 433 |
SKIN LACERATION |
2 |
0.0002 |
| 434 |
OROPHARYNGEAL PAIN |
17 |
0.0002 |
| 435 |
JAW DISORDER |
1 |
0.0002 |
| 436 |
SKIN LESION |
5 |
0.0002 |
| 437 |
ASTHENOPIA |
1 |
0.0002 |
| 438 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 439 |
WOUND |
5 |
0.0002 |
| 440 |
SKIN INFECTION |
2 |
0.0002 |
| 441 |
EYE INFECTION |
2 |
0.0002 |
| 442 |
INTERNAL HAEMORRHAGE |
2 |
0.0002 |
| 443 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 444 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
12 |
0.0002 |
| 445 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
6 |
0.0002 |
| 446 |
NEURALGIA |
4 |
0.0002 |
| 447 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 448 |
GENERALISED OEDEMA |
2 |
0.0002 |
| 449 |
HAIR COLOUR CHANGES |
2 |
0.0002 |
| 450 |
SWELLING OF EYELID |
1 |
0.0002 |
| 451 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 452 |
HERPES SIMPLEX |
1 |
0.0002 |
| 453 |
SKIN BURNING SENSATION |
11 |
0.0002 |
| 454 |
SKIN IRRITATION |
7 |
0.0002 |
| 455 |
BEDRIDDEN |
2 |
0.0002 |
| 456 |
ADVERSE REACTION |
2 |
0.0002 |
| 457 |
PARAESTHESIA |
23 |
0.0001 |
| 458 |
INJECTION SITE REACTION |
10 |
0.0001 |
| 459 |
LYMPHOEDEMA |
1 |
0.0001 |
| 460 |
SKIN EXFOLIATION |
12 |
0.0001 |
| 461 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 462 |
DISSEMINATED INTRAVASCULAR COAGULATION |
2 |
0.0001 |
| 463 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 464 |
FEAR OF INJECTION |
1 |
0.0001 |
| 465 |
GRAFT VERSUS HOST DISEASE |
1 |
0.0001 |
| 466 |
DERMATITIS BULLOUS |
1 |
0.0001 |
| 467 |
RASH PUSTULAR |
1 |
0.0001 |
| 468 |
DYSPHONIA |
8 |
0.0001 |
| 469 |
APPLICATION SITE PAIN |
3 |
0.0001 |
| 470 |
SENSITIVE SKIN |
1 |
0.0001 |
| 471 |
ORAL PAIN |
3 |
0.0001 |
| 472 |
PAIN |
82 |
0.0001 |
| 473 |
VISION BLURRED |
18 |
0.0001 |
| 474 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 475 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 476 |
PHARYNGEAL OEDEMA |
2 |
0.0001 |
| 477 |
ADVERSE DRUG REACTION |
11 |
0.0001 |
| 478 |
ABNORMAL FAECES |
1 |
0.0001 |
| 479 |
EMBOLISM |
1 |
0.0001 |
| 480 |
EOSINOPHIL COUNT INCREASED |
1 |
0.0001 |
| 481 |
HAEMODIALYSIS |
1 |
0.0001 |
| 482 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 483 |
MUSCULOSKELETAL DISCOMFORT |
2 |
0.0001 |
| 484 |
MUSCLE STRAIN |
1 |
0.0001 |
| 485 |
PYELONEPHRITIS |
1 |
0.0001 |
| 486 |
MIGRAINE |
11 |
0.0001 |
| 487 |
MUSCULAR WEAKNESS |
13 |
0.0001 |
| 488 |
JOINT STIFFNESS |
3 |
0.0001 |
| 489 |
MUSCULOSKELETAL STIFFNESS |
10 |
0.0001 |
| 490 |
GROIN PAIN |
1 |
0.0001 |
| 491 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 492 |
COLD SWEAT |
2 |
0.0001 |
| 493 |
URTICARIA |
19 |
0.0001 |
| 494 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 495 |
HEAD DISCOMFORT |
2 |
0.0001 |
| 496 |
THROAT TIGHTNESS |
3 |
0.0001 |
| 497 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 498 |
RETINAL DETACHMENT |
1 |
0.0001 |
| 499 |
ADVERSE EVENT |
10 |
0.0001 |
| 500 |
NERVE COMPRESSION |
1 |
0.0001 |
| 501 |
ACCIDENTAL EXPOSURE TO PRODUCT |
11 |
0.0001 |
| 502 |
PHOTOPHOBIA |
2 |
0.0001 |
| 503 |
LACERATION |
1 |
0.0001 |
| 504 |
ARTERIOSCLEROSIS |
1 |
0.0001 |
| 505 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 506 |
WHITE BLOOD CELL COUNT INCREASED |
4 |
0.0001 |
| 507 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 508 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 509 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 510 |
PREGNANCY |
2 |
0.0001 |
| 511 |
BRAIN INJURY |
1 |
0.0001 |
| 512 |
APHASIA |
3 |
0.0001 |
| 513 |
CELLULITIS |
5 |
0.0001 |
| 514 |
PRODUCT PHYSICAL ISSUE |
2 |
0.0001 |
| 515 |
DRY THROAT |
1 |
0.0001 |
| 516 |
NERVOUS SYSTEM DISORDER |
3 |
0.0001 |
| 517 |
FOLLICULITIS |
1 |
0.0001 |
| 518 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 519 |
JOINT DISLOCATION |
1 |
0.0001 |
| 520 |
WEIGHT INCREASED |
21 |
0.0001 |
| 521 |
PHARYNGITIS STREPTOCOCCAL |
1 |
0.0001 |
| 522 |
ACNE |
7 |
0.0001 |
| 523 |
HYPERSENSITIVITY |
17 |
0.0001 |
| 524 |
IMPAIRED HEALING |
3 |
0.0001 |
| 525 |
TOOTH FRACTURE |
1 |
0.0001 |
| 526 |
GAIT INABILITY |
3 |
0.0001 |
| 527 |
RASH |
39 |
0.0001 |
| 528 |
GLOSSODYNIA |
2 |
0.0001 |
| 529 |
RASH PAPULAR |
2 |
0.0001 |
| 530 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 531 |
NEOPLASM |
1 |
0.0001 |
| 532 |
EYELID OEDEMA |
1 |
0.0001 |
| 533 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 534 |
CHILLS |
10 |
0.0001 |
| 535 |
ACCIDENT |
1 |
0.0001 |
| 536 |
THYROID CANCER |
1 |
0.0001 |
| 537 |
CRYING |
3 |
0.0001 |
| 538 |
VERTIGO |
5 |
0.0001 |
| 539 |
FEELING HOT |
5 |
0.0001 |
| 540 |
INJECTION SITE EXTRAVASATION |
1 |
0.0001 |
| 541 |
AGEUSIA |
2 |
0.0001 |
| 542 |
PEMPHIGUS |
1 |
0.0001 |
| 543 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 544 |
AMNESIA |
5 |
0.0001 |
| 545 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 546 |
INJECTION SITE HAEMORRHAGE |
6 |
0.0001 |
| 547 |
EMOTIONAL DISTRESS |
9 |
0.0001 |
| 548 |
MOOD ALTERED |
2 |
0.0001 |
| 549 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 550 |
PROCEDURAL PAIN |
2 |
0.0001 |
| 551 |
FEELING COLD |
2 |
0.0001 |
| 552 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 553 |
EYE PAIN |
4 |
0.0001 |
| 554 |
DIALYSIS |
1 |
0.0001 |
| 555 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 556 |
EYE IRRITATION |
4 |
0.0001 |
| 557 |
ANOSMIA |
1 |
0.0001 |
| 558 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 559 |
HYPOKINESIA |
1 |
0.0001 |
| 560 |
DYSSTASIA |
2 |
0.0001 |
| 561 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 562 |
DYSGEUSIA |
5 |
0.0001 |
| 563 |
THROAT IRRITATION |
3 |
0.0001 |
| 564 |
BONE LOSS |
1 |
0.0001 |
| 565 |
TINNITUS |
3 |
0.0001 |
| 566 |
CEREBROVASCULAR ACCIDENT |
11 |
0.0001 |
| 567 |
THYROID DISORDER |
1 |
0.0001 |
| 568 |
EMOTIONAL DISORDER |
2 |
0.0001 |
| 569 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 570 |
WEIGHT DECREASED |
18 |
0.0001 |
| 571 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 572 |
CYANOSIS |
1 |
0.0001 |
| 573 |
PREMATURE DELIVERY |
1 |
0.0001 |
| 574 |
FEELING ABNORMAL |
15 |
0.0001 |
| 575 |
GASTROOESOPHAGEAL REFLUX DISEASE |
5 |
0.0001 |
| 576 |
INFLUENZA LIKE ILLNESS |
5 |
0.0001 |
| 577 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 578 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 579 |
FACE OEDEMA |
1 |
0.0001 |
| 580 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
2 |
0.0001 |
| 581 |
FLUID RETENTION |
3 |
0.0001 |
| 582 |
HAEMATURIA |
2 |
0.0001 |
| 583 |
RASH MACULAR |
2 |
0.0001 |
| 584 |
HYPOXIA |
2 |
0.0001 |
| 585 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 586 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 587 |
OSTEOMYELITIS |
1 |
0.0001 |
| 588 |
DRUG EFFECT INCOMPLETE |
2 |
0.0001 |
| 589 |
PELVIC PAIN |
1 |
0.0001 |
| 590 |
PRURITUS |
21 |
0.0001 |
| 591 |
HAEMATOCHEZIA |
3 |
0.0001 |
| 592 |
HYPERHIDROSIS |
7 |
0.0001 |
| 593 |
HEADACHE |
34 |
0.0001 |
| 594 |
MEDICATION ERROR |
3 |
0.0001 |
| 595 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 596 |
INCREASED APPETITE |
1 |
0.0001 |
| 597 |
BLOOD PRESSURE INCREASED |
8 |
0.0001 |
| 598 |
DIZZINESS |
26 |
0.0001 |
| 599 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 600 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 601 |
PALPITATIONS |
6 |
0.0001 |
| 602 |
SKIN FISSURES |
1 |
0.0001 |
| 603 |
SYNCOPE |
5 |
0.0000 |
| 604 |
FEEDING DISORDER |
1 |
0.0000 |
| 605 |
PRODUCT USE IN UNAPPROVED INDICATION |
12 |
0.0000 |
| 606 |
INFECTION |
7 |
0.0000 |
| 607 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 608 |
RETCHING |
1 |
0.0000 |
| 609 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 610 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 611 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 612 |
SEPTIC SHOCK |
2 |
0.0000 |
| 613 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 614 |
TOOTH DISORDER |
1 |
0.0000 |
| 615 |
SEPSIS |
5 |
0.0000 |
| 616 |
SNEEZING |
1 |
0.0000 |
| 617 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 618 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 619 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 620 |
PYREXIA |
15 |
0.0000 |
| 621 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 622 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
2 |
0.0000 |
| 623 |
ANXIETY |
12 |
0.0000 |
| 624 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 625 |
VISUAL IMPAIRMENT |
5 |
0.0000 |
| 626 |
DRY EYE |
2 |
0.0000 |
| 627 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 628 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 629 |
ACUTE KIDNEY INJURY |
6 |
0.0000 |
| 630 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 631 |
RASH GENERALISED |
1 |
0.0000 |
| 632 |
DIPLOPIA |
1 |
0.0000 |
| 633 |
HAEMORRHAGE |
4 |
0.0000 |
| 634 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 635 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 636 |
DERMATITIS ATOPIC |
2 |
0.0000 |
| 637 |
DEPRESSED MOOD |
2 |
0.0000 |
| 638 |
CHEST PAIN |
7 |
0.0000 |
| 639 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 640 |
EAR INFECTION |
1 |
0.0000 |
| 641 |
DRY SKIN |
5 |
0.0000 |
| 642 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 643 |
JAUNDICE |
1 |
0.0000 |
| 644 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 645 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 646 |
DRY MOUTH |
3 |
0.0000 |
| 647 |
RASH PRURITIC |
2 |
0.0000 |
| 648 |
RENAL IMPAIRMENT |
3 |
0.0000 |
| 649 |
ANGINA PECTORIS |
1 |
0.0000 |
| 650 |
HYPERSOMNIA |
1 |
0.0000 |
| 651 |
SEIZURE |
4 |
0.0000 |
| 652 |
PANCREATIC CARCINOMA |
1 |
0.0000 |
| 653 |
PRODUCT STORAGE ERROR |
3 |
0.0000 |
| 654 |
BONE PAIN |
2 |
0.0000 |
| 655 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 656 |
WHEEZING |
2 |
0.0000 |
| 657 |
IRRITABILITY |
2 |
0.0000 |
| 658 |
PREMATURE BABY |
1 |
0.0000 |
| 659 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 660 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 661 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 662 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 663 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 664 |
NIGHT SWEATS |
1 |
0.0000 |
| 665 |
DEPRESSION |
7 |
0.0000 |
| 666 |
EYE DISORDER |
1 |
0.0000 |
| 667 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 668 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 669 |
VIRAL INFECTION |
1 |
0.0000 |
| 670 |
INSOMNIA |
8 |
0.0000 |
| 671 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 672 |
FLUSHING |
3 |
0.0000 |
| 673 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 674 |
SINUSITIS |
3 |
0.0000 |
| 675 |
HEART RATE DECREASED |
1 |
0.0000 |
| 676 |
INJURY |
2 |
0.0000 |
| 677 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 678 |
MOBILITY DECREASED |
2 |
0.0000 |
| 679 |
PANIC ATTACK |
1 |
0.0000 |
| 680 |
RESTLESSNESS |
1 |
0.0000 |
| 681 |
DYSURIA |
1 |
0.0000 |
| 682 |
DISORIENTATION |
1 |
0.0000 |
| 683 |
MALAISE |
11 |
0.0000 |
| 684 |
JOINT SWELLING |
3 |
0.0000 |
| 685 |
BLINDNESS |
1 |
0.0000 |
| 686 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 687 |
HYPOACUSIS |
1 |
0.0000 |
| 688 |
OVERDOSE |
5 |
0.0000 |
| 689 |
BALANCE DISORDER |
2 |
0.0000 |
| 690 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 691 |
MENTAL DISORDER |
1 |
0.0000 |
| 692 |
INTENTIONAL PRODUCT MISUSE |
2 |
0.0000 |
| 693 |
NAUSEA |
18 |
0.0000 |
| 694 |
ANGIOEDEMA |
1 |
0.0000 |
| 695 |
DEHYDRATION |
3 |
0.0000 |
| 696 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 697 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 698 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 699 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 700 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 701 |
CARDIAC DISORDER |
2 |
0.0000 |
| 702 |
VOMITING |
10 |
0.0000 |
| 703 |
DYSPNOEA |
12 |
0.0000 |
| 704 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 705 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 706 |
NERVOUSNESS |
1 |
0.0000 |
| 707 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 708 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 709 |
ARTHROPATHY |
1 |
0.0000 |
| 710 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 711 |
HERPES ZOSTER |
1 |
0.0000 |
| 712 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 713 |
SURGERY |
1 |
0.0000 |
| 714 |
NASAL CONGESTION |
1 |
0.0000 |
| 715 |
PAIN IN EXTREMITY |
5 |
0.0000 |
| 716 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 717 |
STOMATITIS |
1 |
0.0000 |
| 718 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 719 |
MUSCLE SPASMS |
3 |
0.0000 |
| 720 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 721 |
RHINORRHOEA |
1 |
0.0000 |
| 722 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 723 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 724 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 725 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 726 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 727 |
SLEEP DISORDER |
1 |
0.0000 |
| 728 |
BRONCHITIS |
1 |
0.0000 |
| 729 |
EPISTAXIS |
1 |
0.0000 |
| 730 |
ASTHENIA |
5 |
0.0000 |
| 731 |
HOT FLUSH |
1 |
0.0000 |
| 732 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 733 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 734 |
BACK PAIN |
3 |
0.0000 |
| 735 |
DIARRHOEA |
8 |
0.0000 |
| 736 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 737 |
MYALGIA |
2 |
0.0000 |
| 738 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 739 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 740 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 741 |
COVID-19 |
2 |
0.0000 |
| 742 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 743 |
DEVICE ISSUE |
1 |
0.0000 |
| 744 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 745 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 746 |
COUGH |
3 |
0.0000 |
| 747 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 748 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 749 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 750 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 751 |
HEART RATE INCREASED |
1 |
0.0000 |
| 752 |
ILLNESS |
1 |
0.0000 |
| 753 |
CONSTIPATION |
2 |
0.0000 |
| 754 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 755 |
FATIGUE |
6 |
0.0000 |
| 756 |
RENAL FAILURE |
1 |
0.0000 |
| 757 |
HOSPITALISATION |
1 |
0.0000 |
| 758 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 759 |
TREMOR |
1 |
0.0000 |
| 760 |
FALL |
2 |
0.0000 |
| 761 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 762 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 763 |
SOMNOLENCE |
1 |
0.0000 |
| 764 |
ARTHRALGIA |
2 |
0.0000 |
| 765 |
HYPERTENSION |
1 |
0.0000 |
| 766 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 767 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 768 |
DEATH |
1 |
0.0000 |